Apollo Endosurgery, CSA Medical & more — 3 GI company key notes

Here are three updates on GI companies from the past week:

The FDA awarded Apollo Endosurgery's OverStitch Sx system FDA 510(k) clearance.

The FDA granted Ferring Pharmaceuticals approval to market Clenpiq, an oral solution for colon preparation.

CSA Medical announced the enrollment of the first patient into a multicenter study evaluating its spray cryotherapy on esophageal cancer patients. The patient was treated at Chapel Hill-based University of North Carolina's Center for Esophageal Diseases and Swallowing.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Learning Opportunities

Featured Webinars

Featured Whitepapers

Featured Podcast